Search Results for

*

1-20 of 20 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Anticoagulation for the Long-term Treatment of VTE in Patients with Cancer - Cochrane ...

Jun 1, 2019 - Low-molecular-weight heparin (LMWH), vitamin K antagonists, and direct oral anticoagulants, when used to prevent recurrent VTE, have a similar impact on all-cause mortality.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2019/0601/p676.html

Prophylactic Vaccination Against Human Papillomavirus to Prevent Cervical Cancer and ...

Jan 1, 2019 - HPV vaccination in women 15 to 26 years of age prevents the development of cervical intraepithelial neoplasia (CIN) 2 and CIN 3 in women regardless of previous HPV exposure (number needed to treat [NNT] = 39). No serious adverse effects are associated with administration of the HPV ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2019/0101/p15.html

Yoga for Cancer-Related Symptoms in Women with Breast Cancer - Cochrane for Clinicians ...

Oct 1, 2017 - Yoga improves health-related quality of life, reduces sleep disturbances, and decreases fatigue in the short term (up to 12 weeks) among women diagnosed with breast cancer who have completed cancer-related treatment or are receiving cancer treatment compared with no intervention.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2017/1001/p434.html

Interventions to Increase Cervical Cancer Screening Rates - Cochrane for Clinicians - ...

Mar 1, 2012 - Invitation letters are the most studied method of encouraging cervical cancer screening, and they are effective (relative risk [RR] = 1.44; 95% confidence interval [CI], 1.24 to 1.52).1–3 Invitation letters may be more cost-effective than more intensive recruitment efforts (e.g., ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2012/0301/p443.html

Effect of Mammography on Breast Cancer Mortality - Cochrane for Clinicians - American ...

Dec 1, 2011 - Although mammography can lead to false-positive results, emotional stress, and unnecessary biopsies, it appears to reduce deaths from breast cancer by about 15 percent.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2011/1201/p1225.html

Screening for the Early Detection and Prevention of Oral Cancer - Cochrane for ...

May 1, 2011 - Screening by visual inspection of the oral cavity does not appear to reduce deaths from oral cancer in the general population, although there is some evidence that it could be effective in high-risk patients who use tobacco and alcohol.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2011/0501/p1047.html

Screening for Prostate Cancer: Prostate-Specific Antigen Testing Is Not Effective - ...

Apr 1, 2011 - Several large randomized controlled trials show that PSA screening does not significantly reduce prostate cancer mortality, even in a U.S. study that included black men and men with a family history of prostate cancer. However, PSA screening does lead to overdiagnosis, overtreatment, ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2011/0401/p802.html

Exercise for the Management of Cancer-Related Fatigue - Cochrane for Clinicians - ...

Oct 1, 2009 - Aerobic and resistance-training exercise programs lead to decreased overall fatigue and an improved quality of life during and after treatment of cancer.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2009/1001/p689.html

Anticoagulation for the Long-term Treatment of VTE in Patients with Cancer - Cochrane ...

Jul 1, 2009 - Although LMWH appears to be more effective than oral anticoagulants in the prevention of recurrent VTE, this does not translate into a survival benefit. LMWH and oral anticoagulants have the same reported adverse events of bleeding and thrombocytopenia.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2009/0701/p30.html

Cancer Genetic Risk Assessment for Individuals at Risk of Familial Breast Cancer - ...

Feb 15, 2008 - Based on limited evidence from three trials, cancer genetic risk assessment reduces distress, improves accuracy of perceived breast cancer risk, and increases breast cancer and genetics knowledge.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2008/0215/p449.html

Counseling Women About Mammography: Benefits vs. Harms - Cochrane for Clinicians - ...

Sep 1, 2007 - Studies of mammography show a 0.1 percent absolute reduction in breast cancer mortality with mammography. This means that if 2,000 women are offered mammography over 10 years, one woman would have her life prolonged, 10 healthy women would be treated unnecessarily for breast cancer, and...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0901/p652.html

Fecal Occult Blood Tests Reduce Colorectal Cancer Mortality - Cochrane for Clinicians -...

Jun 1, 2007 - Fecal occult blood testing reduces colorectal cancer mortality by 16 percent. Annual testing and rehydration of samples increases testing sensitivity but also increases the number of false-positive results.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0601/p1652.html

Screening for Prostate Cancer - Cochrane for Clinicians - American Family Physician

Feb 1, 2007 - There is insufficient evidence to determine whether screening for prostate cancer reduces mortality or impacts quality of life.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2007/0201/p336.html

Opioids for Management of Breakthrough Pain in Cancer Patients - Cochrane for ...

Dec 1, 2006 - Oral transmucosal fentanyl citrate (OTFC [Actiq]), a rapid-acting opioid, has been shown to be an effective treatment for breakthrough cancer pain. Other opioids, including immediate-release oral morphine (MSIR), also may be effective; however, evidence comparing these agents with OTFC ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2006/1201/p1855.html

NSAIDs Alone or with Opioids as Therapy for Cancer Pain - Cochrane for Clinicians - ...

Aug 1, 2005 - Short-term trials indicate that cancer pain can be reduced with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) as initial monotherapy. NSAIDs combined with opioids can result in slight short-term improvement in pain compared with either agent alone. Long-term efficacy and ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2005/0801/p436.html

Follow-up After Surgically Treated Breast Cancer - Cochrane for Clinicians - American ...

Jul 1, 2005 - The best available evidence supports clinical breast examinations every three to six months for five years and annual mammography for asymptomatic breast cancer survivors. More intensive follow-up and subspecialist visits do not improve survival.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2005/0701/p77.html

Efficacy of Antioxidants in GI Cancer Prevention - Cochrane for Clinicians - American ...

Feb 1, 2005 - There is no evidence that supplementation with beta carotene or vitamins A, C, or E prevents GI cancer. Data for selenium is inconsistent and based on poor-quality studies, and supplementation with this mineral should not be recommended routinely. Most importantly, combinations of ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2005/0201/p465.html

What Is the Best Collection Device for Screening Cervical Smears? - Cochrane for ...

Apr 1, 2004 - The combination of an extended-tip spatula with an endocervical brush (Cytobrush) is the most effective method for obtaining cervical cells. Detection of endocervical cells is a good indication of adequate smears and detection of disease.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2004/0401/p1661.html

Cochrane for Clinicians - Dec 1, 2004 - American Family Physician

Dec 1, 2004 - Combined evidence from two clinical trials of calcium supplementation lasting for several years revealed a reduced rate of recurrent colorectal adenoma. However, evidence is insufficient to recommend supplementation with dietary calcium for patients who have never had an adenoma.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2004/1201/p2109.html

Should We Offer Routine Breast Cancer Screening with Mammography? - Cochrane for ...

Jul 15, 2003 - While there is good evidence that mammography starting at age 50 reduces breast cancer mortality, this meta-analysis does not provide evidence of a mortality benefit for mammography screening in women aged 40 to 49. Controversy exists over whether to include in the analysis trials with ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2003/0715/p260.html

Page  1

25 50 100 results per page